Structured evidence table for Phosphorus Bone Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Phosphorus Bone Health Randomized Trial | The prevalence rate in people over 65 years old increased to 32.0%, and that of women was as high as 51.6% []. | 3 | Osman Henigul (2026) | Research Progress on Mechanisms of Milk-Derived Functional Components in Regulating Bone Health and the Gut–Bone Axis |
| Phosphorus Bone Health Randomized Trial | Further studies have shown that the absolute burden of osteoporosis in menopausal women continues to increase, with the highest risk in low-and middle-income countries and women over 85 years of age []. | 3 | Osman Henigul (2026) | Research Progress on Mechanisms of Milk-Derived Functional Components in Regulating Bone Health and the Gut–Bone Axis |
| Phosphorus Bone Health Randomized Trial | These drugs have the characteristics of high cost-effectiveness and medicinal value, convenient use, effective improvement of bone mineral density, and reduction of fracture risk. | 3 | Osman Henigul (2026) | Research Progress on Mechanisms of Milk-Derived Functional Components in Regulating Bone Health and the Gut–Bone Axis |
| Phosphorus Bone Health Randomized Trial | 1 2 3 Bone serves as the fundamental structural framework that maintains the integrity of the organism and supports motor function, and its metabolic homeostasis depends on a delicate and tightly regulated balance between bone formation mediated by osteoblasts and bone resorption mediated by osteoclasts []. | 3 | Osman Henigul (2026) | Research Progress on Mechanisms of Milk-Derived Functional Components in Regulating Bone Health and the Gut–Bone Axis |
| Phosphorus Bone Health Randomized Trial | Calcium and vitamin D are well-established for maintaining bone mass and reducing fracture risk, particularly in deficient or high-risk populations, whereas evidence supporting the roles of vitamin K, magnesium, and phosphorus is more limited and population specific. | 3 | da Silva Tiago Donizeti Bertolacini (2025) | Supplements for bone health |
| Phosphorus Bone Health Randomized Trial | 1 2 3 This review has three primary objectives: () to delineate the physiological functions of calcium, vitamin D, vitamin K, magnesium, and phosphorus in bone metabolism; () to summarize current dietary intake recommendations and evaluate the Brazilian context; () to synthesize evidence from meta-analyses and systematic reviews regarding their impact on bone health. | 3 | da Silva Tiago Donizeti Bertolacini (2025) | Supplements for bone health |
| Phosphorus Bone Health Randomized Trial | Conversely, elevated serum calcium levels suppress PTH secretion through negative feedback, leading to decreased bone resorption and reduced calcium reabsorption in the kidneys (,). | 3 | da Silva Tiago Donizeti Bertolacini (2025) | Supplements for bone health |
| Phosphorus Bone Health Randomized Trial | Bone health is determined by a complex interplay of genetic, hormonal, and environmental factors, with nutrient intake representing an important contributor to skeletal integrity. | 3 | da Silva Tiago Donizeti Bertolacini (2025) | Supplements for bone health |
Source documents